the market?
VIVUS, Inc.
NASDAQ: VVUS
12.30
-0.24
(-1.91%)
| Today's Open | $12.63 |
|---|---|
| Previous Close | $12.54 |
| Daily Range | $12.20 - $12.71 |
| 52-Week Range | $9.86 - $31.21 |
| Market Cap | $1.2B |
| P/E Ratio | -7.17 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,538,032 |
| Average Daily Volume | 2,461,514 |
| Current FY EPS | -$1.97 |
How do you think VVUS
will perform against the market?
Top VVUS Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
June 15, 2010
I had Vivus on my watchlist to green thumb under 11 ahead of the FDA advisory panel for Qnexa on July 15, and surely enough they dropped a clean point today and slipped under my threshold. Some jitter … More
News & Commentary
Weight Loss Isn't Just for Looking Good Anymore
Medical benefits are helping obesity drugs get coverage. Will the government help?Vivus Increases Board to 9 Members
The pharma company announces its second and third new board members in two weeks.4 Technologies That Can Help Track Weight Loss
Apps and devices that help patients being treated for obesity track their progress.Deal Discussions Distract From Disappointing Obesity Drug Sales
Making sense of Vivus' first quarter results for investors.Is the Golden Age of Blockbusters Over?
Big Pharma enjoyed a pretty historic run in the last two decades. But with the patent cliff stifling industry growth, is the Golden Age of the Blockbuster over for good? This one might be, but investors cannot rule out future opportunities.These Stocks Sent the Dow Soaring Again
Investors are starting to take records for granted.Sector
Healthcare
Industry
Drugs
VIVUS, Inc. (VVUS) Description
A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website: http://www.vivus.com/
